CARDLYTICS, INC. (CDLX) Operating cash flow 2016–2025
CARDLYTICS, INC. (CDLX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$9.3MFY2025 · since FY2016: -$32.5M → $9.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.3M | +205.3% |
| FY2024 | -$8.8M | -4669.7% |
| FY2023 | -$185,000 | +99.7% |
| FY2022 | -$53.9M | -39.9% |
| FY2021 | -$38.5M | -407.0% |
| FY2020 | -$7.6M | -166.3% |
| FY2019 | $11.5M | +160.3% |
| FY2018 | -$19.0M | +14.1% |
| FY2017 | -$22.1M | +32.0% |
| FY2016 | -$32.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CDLX financial trends
CDLX RevenueCDLX Net incomeCDLX Net marginCDLX Gross profitCDLX Gross marginCDLX Operating incomeCDLX Operating marginCDLX Free cash flowCDLX Capital expendituresCDLX Return on equityCDLX Stock buybacksCDLX Dividends paidCDLX Total assetsCDLX Total liabilitiesCDLX Shareholders’ equityCDLX overview →